Faculty of Health Sciences
School of Medicine
Department of Pharmacology
Development of anti-cancer agents - Research Output
Research articles in refereed specialist journals:
Michie J, Akudugu J, Binder A, Van Rensburg-Medlen CEJ, Böhm L: 2004. Flow cytrometric evaluation of apoptosis and cell viability as a criterion of anti-tumour drug toxicity. Anticancer Research, 23, pp 2675-2680.
Weber B, Serafin A, Michie J, Van Rensburg-Medlen CEJ, Swarts JC, Böhm L: 2004. Cytotoxicity and cell death pathways invoked by two new Rhodium-Ferrocene complexes in benign and malignant prostatic cell lines. Anticancer Research, 24, pp 763-770.
Patents:
Swarts JC, Van Rensburg-Medlen CEJ: 2004. Ferrocene Compounds: A substance or composition for the treatment of cancer. (PCT/IBO 1/02258).
|
